Sucralose safe to use in small doses; reveals MDRF study
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
Observes no adverse impact of non-nutritive sweetener (NNS) - sucralose on glycemic markers
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
The inspection closed with five observations which were more of procedural changes with none of these related to data integrity
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Dyslipidemia is a critical risk factor for cardiovascular diseases
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
This strategic decision will unlock significant value for our scientific and industrial products business
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
Subscribe To Our Newsletter & Stay Updated